Clinical Study on Anti-Dandruff Herbal Shampoo

A prospective, open label, one arm study to evaluate the safety and efficacy of LAFZ ETHNIC Tea Tree Oil & Lemon Refreshing Anti-Dandruff Herbal Shampoo in reduction of mild to moderate dandruff in healthy male or female volunteers

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/12/048288

Enrollment

Registered

2022-12-20

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L219- Seborrheic dermatitis, unspecified

Interventions

Intervention1: LAFZ ETHNIC Tea Tree Oil & Lemon Refreshing Anti-Dandruff Herbal Shampoo: Dosage form: Liquid, Usage: Wet your hair. Take a coin-sized dollop of shampoo and work it into a lather. Gentl

Eligibility

Inclusion criteria

Inclusion criteria: • Healthy Indian male/female volunteer aged between 18-45 years (both inclusive) • Willing to give Informed Consent • Subjects diagnosed with of mild to moderate dandruff, assessed by mean total Adherent Scalp Flaking Score (ASFS) of 8 zones in the scalp. • Willing to complete the study assessments/questionnaires. • Willing to avoid usage of his/her own hair care products in controlling hair fall and dandruff for at least one week before the commencement and during this study.

Exclusion criteria

Exclusion criteria: • Pregnancy or breast feeding. • Patients diagnosed with severe dandruff, Itching, flaking, pruritis and visible inflammation over face, retro auricular area, and the upper chest. • Patients with inflammatory or infective scalp conditions. • Patients with history of hypersensitivity to hair products • Patients with mild to severe anaphylaxis reaction. • Patients with pre existing severe systemic disease necessitating long term medication. • Evidence of significant uncontrolled co morbid disease which in the investigators opinion would jeopardize patient participation. • History of cancer, including solid tumors, hematologic malignancies and carcinoma in situ. • Participation in the current or previous clinical trial with any approved or investigational products during the past 1 month.

Design outcomes

Primary

Measure	Time frame
â?¢Reduction of dandruff through Adherent Scalp Flaking Score (ASFS) from baseline to end of the study.Timepoint: Day 0 to Day 30	—

Secondary

Measure	Time frame
â?¢ Consumer feedback will be obtained via a set of subjective questionnaires to evaluate the response towards the product.Timepoint: Day 0 to Day 30	—

Countries

India

Contacts

Public ContactDr Ashok Godavarthi

Radiant Research Services Pvt. Ltd

ashok@radiantresearch.in9880999297

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026